Ocular and Adnexal Lymphoma

Arun Dev Singh, MD, is Director of the Department of Ophthalmic Oncology at the Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio. Dr. Singh studied at the University of Madras and the All India Institute of Medical Sciences, New Delhi, before gaining his FRCS (Royal College of Surgeons, Edinburgh) and FRCOphth (Royal College of Ophthalmologists) in the United Kingdom. He trained and worked at Wills Eye Hospital in Philadelphia before taking up his present position in 2003. In 2009 Dr. Singh received a Senior Achievement Award from the American Academy of Ophthalmology. Since 2009 he has also been Professor of Ophthalmology at the Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio. Dr. Singh is co-Editor-in-Chief of the British Journal of Ophthalmology. He has authored more than 100 book chapters and more than 250 journal articles and has edited 10 books. He has been an invited speaker at several universities, including Harvard University, Yale University, Cambridge University, and Emory University.

From the book reviews: "This well written text covers the spectrum of eye-related presentations of lymphoma in a concise yet thorough manner that can easily be read in a single sitting. ... serves as an in-depth and up-to-date source of knowledge needed to diagnose and treat ocular, orbital, and periocular lymphoma. ... highly recommended as a reference for any disease entity within the classification of ocular and adnexal lymphoma. It should be useful to ocular pathologists, ocular oncologists, retina specialists, and comprehensive ophthalmologists alike." (Shree K. Kurup, Kevin S. Chen, Victor T. Copeland and James R. Lomax III, Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 252 (11), November, 2014)

• Classification Systems.- Histopathology.- Molecular Pathology.- Epidemiological Aspects.- Clinical Features and Diagnostic Evaluation.- Biopsy Techniques.- Staging and Treatment.- Vitreo Retinal Lymhoma: Staging and Treatment.- Ocular and Adnexal Benign Reactive Lymphoid Hyperplasia.- Ocular and Adnexal T Cell Lymphoma.